Literature DB >> 7574538

In vitro antibiotic susceptibility testing of clinical isolates of Mycoplasma penetrans from patients with AIDS.

M M Hayes1, H H Foo, J Timenetsky, S C Lo.   

Abstract

In vitro susceptibilities of Mycoplasma penetrans were determined. MICs and MBCs were determined. The MICs at which 50% of the isolates are inhibited (micrograms per milliliter) for broth dilution testing were as follows: azithromycin, 0.039; chloramphenicol, 0.625; ciprofloxacin, 0.156; clindamycin, 0.078; doxycycline, 0.312; erythromycin, 0.312; gentamicin. > 10; levofloxacin, 0.078; lincomycin, 0.625; streptomycin, > 10; and tetracycline, 1.25. Bactericidal activity was significant only for ciprofloxacin (MBC at which 50% of the isolates are killed, 0.312 microgram/ml) and levofloxacin (MBC at which 50% of the isolates are killed, 0.312 microgram/ml).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574538      PMCID: PMC162749          DOI: 10.1128/AAC.39.6.1386

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

Review 1.  Use of quinolones in the immunocompromised host.

Authors:  A G Maiche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

2.  Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.

Authors:  G E Kenny; T M Hooton; M C Roberts; F D Cartwright; J Hoyt
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

3.  Studies on the nature of receptors involved in attachment of tissue culture cells to mycoplasmas.

Authors:  R J Manchee; D Taylor-Robinson
Journal:  Br J Exp Pathol       Date:  1969-02

4.  Newly discovered mycoplasma isolated from patients infected with HIV.

Authors:  S C Lo; M M Hayes; R Y Wang; P F Pierce; H Kotani; J W Shih
Journal:  Lancet       Date:  1991-12-07       Impact factor: 79.321

5.  Genomic and phenotypic analyses of Mycoplasma pneumoniae strains.

Authors:  D K Chandler; S Razin; E B Stephens; R Harasawa; M F Barile
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy.

Authors:  C B Smith; W T Friedewald; R M Chanock
Journal:  N Engl J Med       Date:  1967-05-25       Impact factor: 91.245

7.  Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma species to antimicrobial agents.

Authors:  E A Ter Laak; A Pijpers; J H Noordergraaf; E C Schoevers; J H Verheijden
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

8.  Histopathology and doxycycline treatment in a previously healthy non-AIDS patient systemically infected by Mycoplasma fermentans (incognitus strain).

Authors:  S C Lo; C L Buchholz; D J Wear; R C Hohm; A M Marty
Journal:  Mod Pathol       Date:  1991-11       Impact factor: 7.842

9.  Evaluation and use of a micro-broth dilution procedure for testing sensitivity of fermentative avian mycoplasmas to antibiotics.

Authors:  K G Whithear; D D Bowtell; E Ghiocas; K L Hughes
Journal:  Avian Dis       Date:  1983 Oct-Dec       Impact factor: 1.577

10.  Mycoplasma penetrans sp. nov., from the urogenital tract of patients with AIDS.

Authors:  S C Lo; M M Hayes; J G Tully; R Y Wang; H Kotani; P F Pierce; D L Rose; J W Shih
Journal:  Int J Syst Bacteriol       Date:  1992-07
View more
  3 in total

1.  Mycoplasma penetrans and other mycoplasmas in urine of human immunodeficiency virus-positive children.

Authors:  A I Hussain; W L Robson; R Kelley; T Reid; J D Gangemi
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  High Prevalence of Mycoplasma penetrans in Chlamydia trachomatis Positive Rectal Samples From Men: A Brief Report.

Authors:  Inmaculada Pérez-Prieto; Axel Skafte-Holm; Jørgen Skov Jensen
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

3.  Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation.

Authors:  S Tsai; D J Wear; J W Shih; S C Lo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.